Glutaminase Monoclonal Antibody, Biotin Conjugated
Product Specifications
Background
Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate in the brain. Isoform 2 lacks catalytic activity.
Synonyms
Mitochondrial; AAD20; GLS; GLS1; GLSK_HUMAN; Glutaminase kidney isoform; K-glutaminase; KIAA0838; L-glutamine amidohydrolase; DKFZp686O15119; FLJ10358; GAC; GAM; Glutaminase C; Glutaminase phosphate activated.
Gene ID
2744
Swiss Prot
O94925
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
Glutaminase
Clonality
Monoclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from human GLS1
Applications
WB, IHC-P, IHC-F
Purification
Purified by Protein A.
Concentration
Lot dependent
Dilution
WB (1:300-5000), IHC-P (1:200-400), IHC-F (1:100-500)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
2744
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2011608-01 0.01 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Ask
View Details 
MBS2011608-02 0.05 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Ask
View Details MBS2011608-03 0.1 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Ask
View Details 
MBS2011608-04 0.2 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Ask
View Details